Date: Mar 18, 2015 Source: Business Wire (
click here to go to the source)
NEW YORK--(BUSINESS WIRE)-- SIGA Technologies, Inc. ("SIGA"), a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, announced that it received a letter today from the Hearings Advisor for The NASDAQ Stock Market LLC ("NASDAQ"), indicating that the NASDAQ Hearings Panel has determined to delist the shares of the Company from the NASDAQ Stock Market and accordingly, suspend trading in the Company's shares effective at the open of business on March 20, 2015. SIGA expects its shares to continue to trade on the OTC Markets under the "SIGAQ" symbol.
On September 16, 2014, the Company received a letter from NASDAQ asserting the Company no longer met the continuing listing requirements necessary to maintain its listing on the NASDAQ Global Market as a consequence of the Company filing for relief under Chapter 11 of the United States Bankruptcy Code. The Company's Chapter 11 filing was precipitated by its ongoing litigation with PharmAthene, Inc.
For additional information on the OTC Markets, please visit www.otcmarkets.com.
